Syntax Research, Inc. Merck & Co., Inc. Transaction History
Syntax Research, Inc.
- $156 Billion
- Q3 2025
A detailed history of Syntax Research, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 4,807 shares of MRK stock, worth $446,378. This represents 0.26% of its overall portfolio holdings.
Number of Shares
4,807
Previous 4,006
20.0%
Holding current value
$446,378
Previous $317 Million
27.24%
% of portfolio
0.26%
Previous 0.23%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,877Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...